Parkinson’s disease: Is there a light at the end of a tunnel? (Letter to the Editor)


Parkinson’s disease is the second most common neu- rodegenerative disorder after Alzheimer disease affecting 1% - 2% in people >60 years old and 3% - 4% in people >80.

Share and Cite:

Surguchov, A. (2013) Parkinson’s disease: Is there a light at the end of a tunnel?. Advances in Parkinson's Disease, 2, 116-117. doi: 10.4236/apd.2013.24022.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Jankovic, J. (2008) Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79, 368-376.
[2] Surguchov, A. (2008) Molecular and cellular biology of synucleins. International Review of Cell and Molecular Biology, 270, 225-317.
[3] Bartels, T., Choi, J.G. and Selkoe, D.J. (2011) α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature, 477, 107-110.
[4] Burré, J., Vivona, S., Diao, J., Sharma, M., Brunger, A.T. and Südhof, T.C. (2013) Properties of native brain α-synuclein. Nature, 498, E4-E6
[5] Olanow, C.W. and Brundin, P. (2013) Parkinson’s disease and alpha synuclein: Is Parkinson’s disease a prion-like disorder? Movement Disorders, 28, 31-40.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.